But after years of daily injections, coupled with the ongoing threat of heart disease, kidney failure, blindness and stroke, Cory Wiseman can handle it.

The six-year-old Ashtonfield diabetic will make an emotional journey to Parliament House on November 25 urging parliamentarians to remember those suffering with diabetes when considering new policies and funding decisions for medical research.

Cory will join more than 40 children from across the State with type 1 diabetes as part of the inaugural Juvenile Diabetes Research Foundation’s Kids in the House event.

It is the first time children from across the State have worked in unison to make their voices heard by the State’s decision makers.

As one of the delegates, and one of more than 140,000 Australians living with type 1 diabetes, Cory will meet with Member for Maitland Frank Terenzini to give a personal account of his experience, highlighting the devastating complications, life-altering impact of the disease and why finding a cure is so important.

“I am really looking forward to meeting with my MP, to share my experiences about living with this disease and explain why a cure is so important. Lots of people think I got type 1 diabetes because I ate too much sugar, but that’s not right at all,” Cory said.

“My pancreas doesn’t make insulin, so I have to have needles. We need more research so that kids like me can lead a normal life.”

But at the moment there is no cure for diabetes and Cory faces a future of injections and finger pricks.

“Type 1 diabetes can also bring complications such as amputation, stroke, blindness, kidney failure and heart disease,” Cory’s mum, Julie, said.

“And these complications can start to present after as little as 15 years with the condition.”

Juvenile Diabetes Foundation chief executive officer Mike Wilson said type 1 diabetes is a terrible disease that can’t be prevented.

“We’re working to find a cure so children and adults with diabetes no longer have to endure multiple daily injections, blood glucose tests, like threatening ‘hypos’ and the fear of developing serious complications,” Mr Wilson said.